Clinical Trial Update: Clinical Trial to Evaluate the Efficacy and Safety of Pravafenix Cap to Verify the Superiority Than Atorvastatin [Phase 3]

View source ↗

Summary

Phase 3 trial assessing whether Pravafenix Cap is superior to atorvastatin for combined dyslipidemia; study completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Combined Dyslipidemia

Drugs mentioned

• Pravafenix Cap
• atorvastatin (atorvastatin)

Snippet

Sponsor: Yooyoung Pharmaceutical Co., Ltd. | Conditions: Combined Dyslipidemia | Phase 3 | Status: COMPLETED